The Cigna Group (CI) to Release Quarterly Earnings on Friday

The Cigna Group (NYSE:CI - Get Free Report) is expected to release its Q1 2025 earnings data before the market opens on Friday, May 2nd. Analysts expect The Cigna Group to post earnings of $6.41 per share and revenue of $60.39 billion for the quarter. The Cigna Group has set its FY 2025 guidance at 29.500- EPS.

The Cigna Group (NYSE:CI - Get Free Report) last issued its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period last year, the business posted $6.79 EPS. On average, analysts expect The Cigna Group to post $30 EPS for the current fiscal year and $33 EPS for the next fiscal year.

The Cigna Group Stock Down 0.0 %

The Cigna Group stock traded down $0.10 during mid-day trading on Friday, hitting $335.60. The company had a trading volume of 1,400,117 shares, compared to its average volume of 1,703,667. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The Cigna Group has a 1 year low of $262.03 and a 1 year high of $370.83. The business has a fifty day moving average of $319.82 and a 200 day moving average of $310.44. The stock has a market cap of $91.85 billion, a price-to-earnings ratio of 27.42, a PEG ratio of 0.98 and a beta of 0.51.

The Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 18th. Investors of record on Tuesday, June 3rd will be given a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.80%. The ex-dividend date is Tuesday, June 3rd. The Cigna Group's dividend payout ratio (DPR) is 49.35%.

Insiders Place Their Bets

In other The Cigna Group news, Director Elder Granger sold 2,376 shares of the company's stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $310.35, for a total transaction of $737,391.60. Following the completion of the sale, the director now directly owns 5,471 shares of the company's stock, valued at approximately $1,697,924.85. This represents a 30.28 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Nicole S. Jones sold 4,904 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $1,511,020.48. Following the completion of the transaction, the insider now directly owns 29,421 shares of the company's stock, valued at $9,065,198.52. This represents a 14.29 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 43,751 shares of company stock worth $13,603,991 over the last ninety days. Company insiders own 0.70% of the company's stock.

Hedge Funds Weigh In On The Cigna Group

A hedge fund recently raised its stake in The Cigna Group stock. Brighton Jones LLC boosted its holdings in shares of The Cigna Group (NYSE:CI - Free Report) by 9.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,736 shares of the health services provider's stock after buying an additional 318 shares during the quarter. Brighton Jones LLC's holdings in The Cigna Group were worth $1,032,000 at the end of the most recent quarter. Institutional investors and hedge funds own 86.99% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on CI. Robert W. Baird decreased their price objective on shares of The Cigna Group from $388.00 to $362.00 and set an "outperform" rating for the company in a research note on Tuesday, April 15th. Guggenheim assumed coverage on The Cigna Group in a research report on Wednesday, April 9th. They issued a "buy" rating and a $384.00 target price for the company. Mizuho lifted their price target on The Cigna Group from $360.00 to $384.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Morgan Stanley decreased their price objective on The Cigna Group from $403.00 to $379.00 and set an "overweight" rating for the company in a report on Friday, January 31st. Finally, Wells Fargo & Company cut their target price on shares of The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating on the stock in a report on Tuesday, February 4th. Two investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and three have issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Buy" and an average price target of $373.56.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.